Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology
Disease Category: Bipolar Disorders
Trial Information
Seroquel in Dysphoric Hypomania
A Double-Blind, Placebo-Controlled Trial of Seroquel for the
Treatment of Dysphoric Hypomania in Bipolar II Patients, Stanford
University Bipolar Disorders Clinic.
We are examining the use of quetiapine (Seroquel) in the
treatment of patients currently experiencing both hypomania and
depressive symptoms (dysphoric hypomania). In this study, after an
initial evaluation phase, patients will be instructed to add
Seroquel or a placebo to their current stable medication regimen
for a period of eight weeks while being monitored by a psychiatrist
using clinical and laboratory measures.
For more information,
Kristine L. Keller, B.S.C.
Stanford University School of Medicine
Bipolar Disorders Clinic
Department of Psychiatry and Behavioral Sciences
401 Quarry Road, Room 2131
Stanford, CA 94305-5723
Phone: 650-498-4968
Fax: 650-723-2507
EMail: klkeller@stanford.edu
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
